EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Unraveling molecular aberrations and pioneering therapeutic strategies in osteosarcoma

Peng Yan, Jie Wang, Bin Yue, Xinyi Wang

Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · 2024-09 · 1879 (5) · 189171

DOI: 10.1016/j.bbcan.2024.189171 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Biochimica et Biophysica Acta (BBA) - Reviews on Cancer, 2024-09. Verfasst von Peng Yan und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Orthopedic Oncology, the Affiliated Hospital of Qingdao University, Qingdao, Shandong 266100, China. Hauptthemen laut MEDLINE: Osteosarcoma, Bone Neoplasms. Die Arbeit wurde bisher 30-mal zitiert (Crossref) und nennt 190 Literaturangaben. Gefördert von: Natural Science Foundation of Shandong Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Osteosarcoma, a rare primary bone cancer, presents diverse molecular aberrations that underscore its complexity. Despite the persistent endeavors by researchers, the limited amelioration in the five-year survival rate indicates that current therapeutic strategies prove inadequate in addressing the clinical necessities. Advancements in molecular profiling have facilitated an enhanced comprehension of the biology of osteosarcoma, offering a promising outlook for treatment. There is an urgent need to develop innovative approaches to address the complex challenges of osteosarcoma, ultimately contributing to enhanced patient outcomes. This review explores the nexus between osteosarcoma and cancer predisposition syndromes, intricacies in its somatic genome, and clinically actionable alterations. This review covers treatment strategies, including surgery, chemotherapy, immune checkpoint inhibitors (ICIs), and tyrosine kinase inhibitors (TKIs). Innovative treatment modalities targeting diverse pathways, including multi-target tyrosine kinases, cell cycle, PI3K/mTOR pathway, and DNA damage repair (DDR), offer promising interventions. This review also covers promising avenues, including antibody-drug conjugates (ADCs) and immunotherapy strategies, such as cytokines, adoptive cellular therapy (ACT), ICIs, and cancer vaccines. This comprehensive exploration contributes to a holistic understanding, offering guidance for clinical applications to advance the management of osteosarcoma.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

OsteosarcomaBone NeoplasmsHumansImmunotherapyMolecular Targeted TherapyImmune Checkpoint Inhibitors

Stichwörter der Autor:innen

Antibody-drug conjugates (ADCs)ImmunotherapyMolecular alterationsOsteosarcomaTargeted therapy

Substanzen

Immune Checkpoint Inhibitors

Autor:innen und Institutionen

  • Department of Orthopedic Oncology, the Affiliated Hospital of Qingdao University, Qingdao, Shandong 266100, China.
  • Department of Orthopedic Oncology, the Affiliated Hospital of Qingdao University, Qingdao, Shandong 266100, China. Electronic address: bonetumoryb@qdu.edu.cn.
  • Department of Pharmacy, the Affiliated Hospital of Qingdao University, Qingdao, Shandong 266100, China. Electronic address: cristinaxinyiwang@qdu.edu.cn.

Förderung

  • Natural Science Foundation of Shandong Province

Zitieren

APA

Yan, P., Wang, J., Yue, B., & Wang, X. (2024). Unraveling molecular aberrations and pioneering therapeutic strategies in osteosarcoma. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer, 1879(5), 189171. https://doi.org/10.1016/j.bbcan.2024.189171

Vancouver

Yan P, Wang J, Yue B, Wang X. Unraveling molecular aberrations and pioneering therapeutic strategies in osteosarcoma. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer. 2024;1879(5):189171. doi:10.1016/j.bbcan.2024.189171

BibTeX
@article{Yan2024,
  author = {Yan, Peng and Wang, Jie and Yue, Bin and Wang, Xinyi},
  title = {Unraveling molecular aberrations and pioneering therapeutic strategies in osteosarcoma},
  journal = {Biochimica et Biophysica Acta (BBA) - Reviews on Cancer},
  year = {2024},
  volume = {1879},
  number = {5},
  pages = {189171},
  doi = {10.1016/j.bbcan.2024.189171}
}
Kostenlos starten →